|
|
||||||||
Journal of Lipid Research, Vol 17, 74-77, Copyright © 1976 by Lipid Research, Inc.
B Dayal, S Shefer, GS Tint, G Salen and EH Mosbach
This paper describes syntheses of 5beta-cholestane-3alpha, 7alpha, 12alpha,
25-tetrol and 5beta-cholestane-3alpha, 7alpha, 12alpha, 24xi, 25-pentol
which give higher yields than previously published methods. In addition,
5beta-cholestane-3alpha, 7alpha, 12alpha, 24xi, 25-pentol was synthesized
by a different procedure, namely via performic acid oxidation of the
correspinding unsaturated triol, which gave a lower yield but avoided the
formation of 5beta-cholestane-3alpha, 7alpha, 12alpha, 25, 26-pentol, which
normally tends to contaminate the final product. Structures were confirmed
by gas-liquid chromatography, infrared-, proton magnetic resonance- and
mass spectrometry, 5beta- Cholestane-3alpha, 7alpha, 12alpha, 25-tetrol and
5beta-cholestane- 3alpha, 7alpha, 12alpha, 24xi, 25-pentol were required
for in vivo and in vitro studies of the (hypothetical) 25-hydroxylation
pathway of cholic acid biosynthesis.
ARTICLES
Synthesis of 5beta-cholestane-3alpha, 7alpha, 12alpha, 25-tetrol and 5beta-cholestane-3alpha, 7alpha, 245, 25-pentol
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Honda, G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, T. Hirayama, G. S. Tint, M. Doy, and S. Shefer Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis J. Lipid Res., February 1, 2005; 46(2): 287 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nishimaki-Mogami, M. Une, T. Fujino, Y. Sato, N. Tamehiro, Y. Kawahara, K. Shudo, and K. Inoue Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor J. Lipid Res., August 1, 2004; 45(8): 1538 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Honda, G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, E. Leitersdorf, G. S. Tint, S. K. Erickson, N. Tanaka, and S. Shefer Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27-/- mice and CTX J. Lipid Res., February 1, 2001; 42(2): 291 - 300. [Abstract] [Full Text] |
||||
![]() |
A. Honda, G. Salen, S. Shefer, Y. Matsuzaki, G. Xu, A. K. Batta, G. S. Tint, and N. Tanaka Regulation of 25- and 27-hydroxylation side chain cleavage pathways for cholic acid biosynthesis in humans, rabbits, and mice: assay of enzyme activities by high-resolution gas chromatography;-mass spectrometry J. Lipid Res., March 1, 2000; 41(3): 442 - 451. [Abstract] [Full Text] |
||||
![]() |
A. Honda, G. Salen, Y. Matsuzaki, A. K. Batta, G. Xu, E. Leitersdorf, G. S. Tint, S. K. Erickson, N. Tanaka, and S. Shefer Side Chain Hydroxylations in Bile Acid Biosynthesis Catalyzed by CYP3A Are Markedly Up-regulated in Cyp27-/- Mice but Not in Cerebrotendinous Xanthomatosis J. Biol. Chem., September 7, 2001; 276(37): 34579 - 34585. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |